Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | November 1, 2005 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00101283 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed disodium|Drug: gemcitabine hydrochloride|Drug: carboplatin |
| Study Design: | Allocation: Randomized|Control: Historical Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | Has Results |
| Sponsors: | Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group |
| Ages: | Adult|Senior |
| Enrollment: | 32 |
| Funded By: | Other|NIH |
| First Received: | January 7, 2005 |
| End Date: | July 1, 2010 |
| Last Updated: | March 23, 2010 |
| Last Verified: | March 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
